Breast Cancer

2014 Breast Cancer Symposium Highlights on the Impact of Breast Cancer Screening Reminders, with Julia White, MD

The following is a transcript of a podcast led by Dr. Julia White, who discusses one study highlighted at the 2014 Breast Cancer Symposium that presents research on the impact of sending reminders to women overdue for breast cancer screening with mammography. Dr. White is Vice Chair of Clinical Research and Director of Breast Radiation Oncology in the Department of Radiation Oncology at the Ohio State University. Dr.

2014 Breast Cancer Symposium Highlights on the Impact of Angelina Jolie’s Story on Genetic Testing, with Harold Burstein, MD, PhD

The following is a transcript of a podcast led by Dr. Harold Burstein, who discusses one study highlighted at the 2014 Breast Cancer Symposium that presents research on the impact that Angelina Jolie’s choice of having surgery to prevent breast cancer had on genetic testing for genes linked to breast cancer risk. Dr.

Taking Zoledronic Acid Less Often After the First Year of Treatment Is Safe for Women with Metastatic Breast Cancer

ASCO Annual Meeting
May 30, 2014

According to new findings from a phase III clinical trial, women taking zoledronic acid (Zometa) for breast cancer that has spread to the bone, called metastases, can safely scale back to a once-every-three-months schedule after finishing a year of monthly treatments.

Pages

Subscribe to RSS - Breast Cancer